Published in Am J Physiol Gastrointest Liver Physiol on June 12, 2008
Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell (2011) 3.36
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology (2012) 2.02
The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands. Gut (2014) 1.53
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol (2012) 1.02
Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proc Natl Acad Sci U S A (2012) 0.99
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics (2012) 0.98
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol (2010) 0.95
LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus? J Exp Clin Cancer Res (2011) 0.93
Barrett esophagus: what a mouse model can teach us about human disease. Cell Cycle (2012) 0.90
The stemness phenotype model. ISRN Oncol (2012) 0.88
Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer (2016) 0.87
Clinical application of transcriptional activators of bile salt transporters. Mol Aspects Med (2013) 0.87
Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations. Mol Aspects Med (2013) 0.85
Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells. Surgery (2009) 0.85
Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy. Dig Dis Sci (2010) 0.85
The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology (2013) 0.84
Barrett's oesophagus: an ideal model to study cancer genetics. Hum Genet (2009) 0.84
Discovery and validation of Barrett's esophagus microRNA transcriptome by next generation sequencing. PLoS One (2013) 0.83
Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20. Dig Dis Sci (2011) 0.82
MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med (2010) 0.82
Barrett's esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver (2014) 0.82
Role of Th-2 cytokines in the development of Barrett's esophagus in rats. J Gastroenterol (2011) 0.82
Research advances in esophageal diseases: bench to bedside. F1000Prime Rep (2013) 0.82
Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol (2014) 0.81
Role of gastrin-peptides in Barrett's and colorectal carcinogenesis. World J Gastroenterol (2012) 0.81
Relationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus. World J Gastroenterol (2013) 0.80
Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis. J Surg Res (2010) 0.79
Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver (2016) 0.78
Microbiome, innate immunity, and esophageal adenocarcinoma. Clin Lab Med (2014) 0.78
Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil (2013) 0.77
Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis. Dig Dis Sci (2012) 0.77
Barrett's esophagus in the patients with familial adenomatous polyposis. Fam Cancer (2014) 0.77
Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus. Cancer Prev Res (Phila) (2011) 0.77
GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers? Gastroenterol Res Pract (2013) 0.77
The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett's esophagus after medical and surgical treatment: a prospective case-control study. Surg Endosc (2014) 0.77
Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1. Neoplasia (2015) 0.77
Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal (2015) 0.76
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. Gastrointest Cancer Res (2012) 0.76
A surprise cell of origin for Barrett's esophagus. Cancer Biol Ther (2012) 0.76
Impact of homeobox genes in gastrointestinal cancer. World J Gastroenterol (2016) 0.75
Inflammation-related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models. Cancers (Basel) (2011) 0.75
The Barrett's Gland in Phenotype Space. Cell Mol Gastroenterol Hepatol (2014) 0.75
Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma. Cancer Prev Res (Phila) (2016) 0.75
Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin. Ann N Y Acad Sci (2016) 0.75
Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium. Differentiation (2016) 0.75
Transgenic overexpression of cdx1b induces metaplastic changes of gene expression in zebrafish esophageal squamous epithelium. Zebrafish (2013) 0.75
Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan. ISRN Gastroenterol (2013) 0.75
Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens. World J Gastroenterol (2014) 0.75
SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas. Cell Mol Gastroenterol Hepatol (2015) 0.75
Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis. World J Gastrointest Pathophysiol (2016) 0.75
From Heartburn to Barrett's Esophagus, and Beyond. World J Surg (2017) 0.75
Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol (2009) 3.65
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut (2011) 2.51
Radiofrequency ablation for refractory gastric antral vascular ectasia (with video). Gastrointest Endosc (2013) 2.16
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut (2012) 2.00
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci (2009) 1.91
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol (2012) 1.81
Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol (2011) 1.50
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology (2002) 1.46
Sorafenib for treatment of hepatocellular carcinoma: a systematic review. Dig Dis Sci (2012) 1.45
Characterization of liver disease and lipid metabolism in the Niemann-Pick C1 mouse. J Cell Biochem (2007) 1.25
Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Dis Esophagus (2008) 1.07
Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae. J Lipid Res (2002) 1.06
Fatal hyperammonemic encephalopathy after gastric bypass surgery. Am J Med (2008) 1.03
Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia. N Engl J Med (2011) 1.01
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci (2010) 0.99
Managing Barrett's oesophagus. BMJ (2003) 0.98
Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol (2004) 0.96
Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett (2008) 0.96
Integrated approach to treatment of children and adults with eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 0.93
High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol (2006) 0.87
Carcinogenesis at the gastroesophageal junction: free radicals at the frontier. Gastroenterology (2002) 0.86
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
Stem cells in Barrett's esophagus: HALOs or horns? Gastrointest Endosc (2008) 0.84
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol (2003) 0.82
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study. Am J Gastroenterol (2007) 0.81
Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (2004) 0.81
Development and characterization of a surgical mouse model of reflux esophagitis and Barrett's esophagus. J Gastrointest Surg (2013) 0.81
Upper gastrointestinal bleeding in a patient with AIDS. Nat Clin Pract Gastroenterol Hepatol (2006) 0.81
Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol (2009) 0.80
The Niemann-Pick C1 protein in feline fibroblasts. Mol Genet Metab (2002) 0.79
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. Am J Physiol Gastrointest Liver Physiol (2007) 0.77
Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis? Clin Gastroenterol Hepatol (2006) 0.77
Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait? Gastroenterology (2008) 0.77
Barrett's Esophagus without dysplasia: wait or ablate? Dig Dis Sci (2011) 0.77
Gastric hyperplastic polyps causing upper gastrointestinal hemorrhage in a young adult. World J Clin Cases (2013) 0.76
Barrett's esophagus: is the goblet half empty? Clin Gastroenterol Hepatol (2012) 0.76
Esophageal human β-defensin expression in eosinophilic esophagitis. Pediatr Res (2013) 0.75
Buried (but not dead) Barrett's metaplasia: tales from the crypts. Gastrointest Endosc (2012) 0.75
Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name? Gut (2016) 0.75